Fin Trust Capital Advisors, LLC Bausch Health Companies Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $510 Million
- Q1 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 109 shares of BHC stock, worth $788. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109
Previous 109
-0.0%
Holding current value
$788
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BHC
# of Institutions
281Shares Held
278MCall Options Held
21.5MPut Options Held
21.8M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$251 Million3.29% of portfolio
-
Goldentree Asset Management LP New York, NY27.6MShares$200 Million23.66% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$191 Million20.29% of portfolio
-
Franklin Resources Inc San Mateo, CA15.9MShares$115 Million0.06% of portfolio
-
National Bank Of Canada15.7MShares$113 Million0.29% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.62B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...